Search for Clinical Trial Results

Sponsored By

Chromophil Renal Cell Carcinoma - 22 Studies Found

Status Study
Recruiting Study Name: Cabozantinib-S-Malate, Crizotinib, Volitinib, or Sunitinib Malate in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
Condition:
  • Recurrent Renal Cell Carcinoma
  • Stage III Renal Cell Cancer
  • Date: 2016-05-02
    Interventions:
    • Drug: Cabozantinib S-malate Gi
Active, not recruiting Study Name: Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer
Condition:
  • Clear Cell Renal Cell Carcinoma
  • Recurrent Renal Cell Carcinoma
  • Biological: Anti-Endoglin Chimeric Monoclonal Antibody TRC105

Terminated Study Name: Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
Condition:
  • Clear Cell Renal Cell Carcinoma
  • Papillary Renal Cell Carcinoma<
    Date: 2004-12-07
    Interventions:
    • Drug: sorafenib tosylate Given
Active, not recruiting Study Name: Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant
Condition:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Adult Acute Lymphoblastic Leukemia in Remissi
    Date: 2004-03-08
    Interventions:
    • Drug: fludarabine phosphate Gi
Active, not recruiting Study Name: Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
Condition:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Adult Acute Lymphoblastic Leukemia in Remissi
    Date: 2000-06-02
    Interventions:
    • Drug: fludarabine phosphate Gi
Completed Study Name: A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Advanced or Metastatic Renal Cell Carcinoma
Condition:
  • Renal Cell Carcinoma
  • Clear-cell Renal Cell Carcinoma
  • Date: 2016-07-13
    Interventions: Drug: CDX-014
Completed Study Name: Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer
Condition:
  • Chromophobe Renal Cell Carcinoma
  • Clear Cell Renal Cell Carcinoma
  • Biological: Bevacizumab Given

Completed Study Name: Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Condition:
  • Childhood Renal Cell Carcinoma
  • Clear Cell Renal Cell Carcinoma
  • Drug: Doxorubicin Hydrochloride

Completed Study Name: Bortezomib in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Date: 2006-01-12
Interventions: Drug: bortezomib
Completed Study Name: Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Date: 2006-11-16
Interventions:
  • Drug: gemcitabine hydrochloride
  • Drug: irin
<<< Previous | Next >>>